Litigation Details for Allergan USA, Inc. v. Sun Pharmaceutical Industries Ltd. (D. Del. 2020)

✉ Email this page to a colleague

Docket	⤷ Try a Trial	Date Filed	2020-10-29
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Parties	JANSSEN PHARMACEUTICA NV
Patents	10,188,632; 7,741,356; 9,675,587
Attorneys	Dominick T. Gattuso
Firms	Heyman Enerio Gattuso & Hirzel LLP
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2020-10-29	1	Complaint	U.S. Patent No. 9,675,587 (“the ’587 patent”) and U.S. Patent No. 10,188,632 (“the ’632 patent”) were…Sun of U.S. Patent No. 7,741,356 (“the ’356 patent”). This action is based upon the Patent Laws of the… THE PATENTS 11. On June 22, 2010, the ’356 patent, titled “Compounds As …’356 patent on September 23, 2014 and May 12, 2020. Janssen is the sole owner of the ’356 patent. Allergan…IV) allegations with respect to the ’587 patent and ’632 patent no earlier than July 31, 2019, and timely	External link to document
2020-10-29	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,741,356 B2. (myr) (Entered:… 29 October 2020 1:20-cv-01479 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2021-07-21	52	Stipulation-General (See Motion List for Stipulation to Extend Time)	Concerning Infringement and Validity of U.S. Patent No. 7,741,356 by Sun Pharmaceutical Industries Ltd.. (… 29 October 2020 1:20-cv-01479 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document